14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ALDR
Delisted

Alder BioPharmaceuticals Stock Price (Quote)

$18.88
+0 (+0%)
At Close: Apr 15, 2020

Range Low Price High Price Comment
30 days $18.88 $18.88 Wednesday, 15th Apr 2020 ALDR stock ended at $18.88. During the day the stock fluctuated 0% from a day low at $18.88 to a day high of $18.88.
90 days $18.88 $18.88
52 weeks $8.39 $19.12

Historical Alder BioPharmaceuticals prices

Date Open High Low Close Volume
Apr 24, 2017 $20.85 $21.60 $20.30 $20.85 905 868
Apr 21, 2017 $20.75 $20.85 $20.05 $20.50 527 874
Apr 20, 2017 $20.70 $21.20 $20.50 $20.75 495 458
Apr 19, 2017 $20.95 $21.45 $20.45 $20.45 508 426
Apr 18, 2017 $20.95 $21.20 $20.42 $20.80 282 816
Apr 17, 2017 $21.70 $21.95 $20.90 $21.10 337 840
Apr 13, 2017 $20.30 $21.90 $20.20 $21.70 693 217
Apr 12, 2017 $19.80 $20.70 $19.60 $20.30 439 462
Apr 11, 2017 $19.50 $19.85 $19.30 $19.75 408 508
Apr 10, 2017 $20.00 $20.21 $19.50 $19.55 437 437
Apr 07, 2017 $19.90 $20.25 $19.60 $19.90 457 744
Apr 06, 2017 $19.60 $20.15 $19.25 $20.05 607 395
Apr 05, 2017 $19.75 $20.50 $19.20 $19.50 669 773
Apr 04, 2017 $20.10 $20.51 $19.40 $19.70 391 345
Apr 03, 2017 $20.90 $21.35 $20.15 $20.20 600 041
Mar 31, 2017 $21.00 $21.45 $20.70 $20.80 384 027
Mar 30, 2017 $21.20 $21.40 $20.70 $21.05 372 937
Mar 29, 2017 $21.10 $21.64 $20.95 $21.20 470 937
Mar 28, 2017 $21.40 $21.65 $20.60 $21.00 317 292
Mar 27, 2017 $21.15 $21.50 $20.80 $21.40 477 375
Mar 24, 2017 $20.75 $21.60 $20.70 $21.35 367 120
Mar 23, 2017 $20.80 $21.30 $20.35 $20.70 418 170
Mar 22, 2017 $20.90 $21.05 $20.00 $20.85 603 735
Mar 21, 2017 $22.20 $22.30 $20.65 $20.80 765 593
Mar 20, 2017 $22.55 $22.77 $21.80 $22.05 400 931
Click to get the best stock tips daily for free!

About Alder BioPharmaceuticals

Alder BioPharmaceuticals Alder BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes therapeutic antibodies in the United States and Australia. The company’s lead product candidate ALD403, an antibody, which is in Phase II clinical trial to target calcitonin gene-related peptide for the prevention of migraine. It also develops ALD1613, which is in preclinical stage to treat patients with congenital adrenal hyperpla... ALDR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT